SC Seeks Response From Union Govt on Plea Over Shortage of HIV Drugs

The NGO Indian Network for People living with HIV/AIDS had moved SC alleging that there is a shortage of antiretroviral drugs in the country.

New Delhi: The Supreme Court has sought response from the Union government and others on a plea alleging shortage of antiretroviral drugs for treating HIV patients in the country.

A bench of Justices D.Y. Chandrachud and Hima Kohli issued notice to the Ministry of Health, National AIDS Control Organisation and others on a plea filed by an NGO.

“The petitioners have submitted that there are shortages in the procurement of ART drugs in the country and the tender for 2021-22, which was due in August 2021, was issued in December 2021 and eventually failed. Issue notice, returnable in two weeks,” the bench said.

Antiretroviral therapy (ART) is treatment of people infected with human immunodeficiency virus (HIV) using anti-HIV drugs.

The top court was hearing a plea filed by NGO Indian Network for People living with HIV/AIDS alleging shortage of antiretroviral drugs in the country.

The plea contended that non-availability of drugs at the Anti Retro Viral Therapy Centres of the National AIDS Control Organisation results in hampering ARV treatment of the people living with HIV/AIDS.

(PTI)

Watch | HIV Patients Protest in Delhi Over Shortage of Life-Saving Drugs

Protesters say the drugs haven’t been available for almost six months.

Claiming a shortage of antiretroviral drugs, HIV patients have been protesting since July 21 outside the National Aids Control Organisation in Delhi.

The protesters say that drugs such as dolutegravir – a relatively new medicine that reduces viral load rapidly — lopinavir and ritonavir — which are used for first and second-line treatment — are in acute shortage. They say the drugs haven’t been available for almost six months.

Here’s a report by The Wire’s Sumedha Pal.